This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
BiotechTV - News
Claim This Podcastby BiotechTV
4.5(9 reviews)
435 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
48
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality82
Social0
YouTube0
Engagement32
Podcast Overview
This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Language
🇺🇲
Publishing Since
1/1/1970
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
48
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality82
Social0
YouTube0
Engagement32
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Publishing Consistency
Every 1 days
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind BiotechTV - News
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
May 31, 2026
ASCO 2026: Fresh off an IPO, Eikon Therapeutics Chairman & CEO Roger Perlmutter describes the scientific idea behind the company, and walks us through the leading programs
Roger Perlmutter, Chairman & CEO of Eikon Therapeutics, discusses the company's scientific vision, leading drug programs, and the transition to a public company in this interview.
May 31, 2026
ASCO 2026: "The results that we presented from the RASolute 302 trial are unprecedented." - The CEO behind this year's pancreatic cancer breakthrough walks us through the full results and implications
Dr. Mark Goldsmith of Revolution Medicines details unprecedented pancreatic cancer trial results and discusses the breakthrough drug's implications and side effects in this interview.
May 5, 2026
London based Cytospire Therapeutics has announced an $83M series A financing to develop first-in-class pan-gamma delta T-cell engagers - the lead program is an EGFR targeting solid tumors
Co-Founder & CEO Natalie Mount explains Cytospire Therapeutics' $83M Series A financing for novel gamma delta T-cell engagers targeting solid tumors.
435 total episodes available with 375 transcripts
Recent guests on BiotechTV - News
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Roger Perlmutter
Guest
Mark Goldsmith
Guest
Natalie Mount
Guest
Philip Astley-Starke
Guest
Robert Allen
Guest
Michel Maharbiz
Guest
Peter Hotez
Guest
Adam May
Guest
Serge Saxonov
Guest
Rajesh Kumar
Guest
Tiago Fauth
Guest
Ram Aiyer
Guest
Similar Podcasts
Discover related shows you might enjoy
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
BioCentury This Week
BioCentury
The Long Run with Luke Timmerman
Timmerman Report
The Readout Loud
STAT
BioVenture VoiCes with Chris Garabedian
BiotechTV
Odd Lots
Bloomberg
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
The Journal.
The Wall Street Journal & Spotify Studios
FT News Briefing
Financial Times
WSJ What’s News
The Wall Street Journal
The BioCentury Show
BioCentury
Business Of Biotech
Ben Comer
Freakonomics Radio
Freakonomics Radio + Stitcher
Economist Podcasts
The Economist
Motley Fool Money
The Motley Fool
Deep-dive analytics for BiotechTV - News
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is BiotechTV - News?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.